Your browser doesn't support javascript.
loading
[Chronic Obstructive Pulmonary Disease]. / Enfermedad pulmonar obstructiva crónica.
García Castillo, Elena; Vargas, Gianna; García Guerra, José Alfonso; López-Giraldo, Alejandra; Alonso Pérez, Tamara.
Afiliação
  • García Castillo E; Servicio de Neumología, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria La Princesa, Universidad Autónoma de Madrid (UAM), Madrid, España. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España.
  • Vargas G; Servicio de Neumología, Hospital Universitario Clínico San Carlos, Madrid, España.
  • García Guerra JA; Servicio Neumología, Hospital La Mancha Centro de Alcázar de San Juan, Ciudad Real, España.
  • López-Giraldo A; Servicio de Neumología, Parc Sanitari Sant Joan de Dèu, Barcelona, España.
  • Alonso Pérez T; Servicio de Neumología, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria La Princesa, Universidad Autónoma de Madrid (UAM), Madrid, España. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España.
Open Respir Arch ; 4(2): 100171, 2022.
Article em Es | MEDLINE | ID: mdl-37497315
ABSTRACT
Chronic Obstructive Pulmonary Disease (COPD) is related to smoking as the main etiological agent although there are other risk factors that can interact influencing the development of the disease. The definition of COPD is based on three points the presence of persistent respiratory symptoms, exposure to risk agents, and a non-reversible obstructive spirometric ratio. Forced spirometry with a bronchodilator test is necessary to confirm the diagnosis of COPD, however, attempts are being made to develop alternative methods for screening given the current significant underdiagnosis of this pathology.In order to advance in a more personalized medicine for the patient, classification tools have been adopted such as clinical phenotypes and treatable traits, allowing treatments to be adapted according to the characteristics of the patients. Non-pharmacological treatment (smoking cessation, vaccination, physical exercise...) are essential for the management of the disease, as well as pharmacological treatment based on clinical phenotypes. Eosinophils have become a key marker when establishing treatment with inhaled glucocorticoids.In the follow-up of the disease, it is very relevant to evaluate the degree of control being a fundamental element the absence of exacerbations given their implications in mortality, morbidity and quality of life of patients. More studies are needed to better define the phenotypes of exacerbations and their biomarkers.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: Es Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: Es Ano de publicação: 2022 Tipo de documento: Article